Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients

Chong Zhao; Runzhi Huang; Zhiwei Zeng; Shaoxin Yang; Wei Lu; Jiali Liu; Yanyu Wei; Hezhou Guo; Yanjie Zhang; Penghui Yan; Zongqiang Huang; Jun Shi

doi:doi:10.18632/aging.203030

← Back

Research Paper Volume 13, Issue 10 pp 14131—14158

Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients

Figure 7. The expression of USP18 protein in EN and LN DLBCL patients. (A) The expression of USP18 protein in EN and LN DLBCL by IHC staining. (B) The H-score of USP18 in tumor tissues of EN and LN DLBCL. (C) The expression of CD83 protein in EN and LN DLBCL by IHC staining. (D) The immunofluorescence double labeled staining of USP18 and CD83 in DLBCL tissues.